We are live on ! Find out more
PIP

Palisades Investment Partners Portfolio holdings

AUM $352M
1-Year Est. Return 76.79%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+76.79%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$10M
Cap. Flow
+$9.07M
Cap. Flow %
3.43%
Top 10 Hldgs %
47.51%
Holding
53
New
4
Increased
43
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$4.48M
2
EEFT icon
Euronet Worldwide
EEFT
+$1.23M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$751K
4
PKE icon
Park Aerospace
PKE
+$628K
5
STRL icon
Sterling Infrastructure
STRL
+$587K

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$2.16M
2
CCRD
CoreCard
CCRD
+$1.35M
3
MPTI.WS
M-tron Industries Warrants
MPTI.WS
+$115K
4
BMI icon
Badger Meter
BMI
+$43.4K

Sector Composition

Rank Sector Weight
1 Industrials 35.98%
2 Healthcare 22.92%
3 Technology 18.12%
4 Financials 13.93%
5 Consumer Discretionary 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRL icon
1
Sterling Infrastructure
STRL
$16.6B
$29.9M 11.28%
97,505
+1,705
+2% +$587K
SPXC icon
2
SPX Corp
SPXC
$10.8B
$23M 8.71%
115,188
+2,749
+2% +$561K
WGS icon
3
GeneDx Holdings
WGS
$2.32B
$11.3M 4.28%
87,164
+2,421
+3% +$332K
KRYS icon
4
Krystal Biotech
KRYS
$9.67B
$10.5M 3.98%
42,765
+1,376
+3% +$290K
MMYT icon
5
MakeMyTrip
MMYT
$5.65B
$9.8M 3.7%
119,375
+1,911
+2% +$157K
MEDP icon
6
Medpace
MEDP
$16.3B
$9.14M 3.45%
16,274
+382
+2% +$217K
ENVA icon
7
Enova International
ENVA
$6.27B
$8.78M 3.32%
55,856
+1,237
+2% +$161K
UFPT icon
8
UFP Technologies
UFPT
$2.42B
$7.8M 2.94%
35,111
+451
+1% +$96.6K
IWM icon
9
iShares Russell 2000 ETF
IWM
$83B
$7.79M 2.94%
31,650
-8,783
-22% -$2.16M
INTA icon
10
Intapp
INTA
$2.93B
$7.67M 2.9%
167,499
+2,446
+1% +$101K
ITRI icon
11
Itron
ITRI
$4.52B
$6.97M 2.63%
75,006
+1,359
+2% +$148K
PKE icon
12
Park Aerospace
PKE
$812M
$6.87M 2.59%
321,745
+31,492
+11% +$628K
VCYT icon
13
Veracyte
VCYT
$3.79B
$6.82M 2.58%
162,043
+3,900
+2% +$157K
CRMD icon
14
CorMedix
CRMD
$589M
$6.71M 2.53%
576,759
+12,653
+2% +$140K
LUNR icon
15
Intuitive Machines
LUNR
$2.61B
$6.61M 2.5%
406,999
+8,428
+2% +$97.6K
PAY icon
16
Paymentus
PAY
$4.85B
$6.33M 2.39%
200,471
+4,473
+2% +$146K
ROOT icon
17
Root
ROOT
$807M
$6.02M 2.27%
83,302
+1,586
+2% +$126K
BMI icon
18
Badger Meter
BMI
$4.02B
$5.92M 2.24%
33,945
-241
-0.7% -$43.4K
MWA icon
19
Mueller Water Products
MWA
$4.19B
$5.77M 2.18%
242,350
+5,894
+2% +$146K
MC icon
20
Moelis & Co
MC
$4.96B
$5.36M 2.02%
77,940
+1,603
+2% +$107K
IESC icon
21
IES Holdings
IESC
$15.3B
$5.31M 2%
13,642
+328
+2% +$132K
TVTX icon
22
Travere Therapeutics
TVTX
$5.78B
$5.26M 1.99%
+137,768
New +$4.48M
PAYS icon
23
Paysign
PAYS
$698M
$4.76M 1.8%
924,373
+26,739
+3% +$144K
ISSC icon
24
Innovative Solutions & Support
ISSC
$360M
$4.53M 1.71%
239,276
+4,953
+2% +$56.4K
SPSC icon
25
SPS Commerce
SPSC
$2.63B
$4.47M 1.69%
50,192
+1,055
+2% +$97.8K
1
2 3

Similar funds

ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
AW
Alaethes Wealth Glenbrook, Nevada $351M AUM 22.79% 1-Year Est. Return
PIC
PCJ Investment Counsel Toronto, Ontario, Canada $352M AUM 68.32% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Palisades Investment Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Palisades Investment Partners held 53 positions worth $265M, up 3.9% from $255M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Palisades Investment Partners deployed $9.07M of net new capital in Q4 2025, opening 4 new positions and adding to 43 existing holdings. Its largest new stake was Travere Therapeutics: 137,768 shares worth $5.26M.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 38% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $2.16M trimmed.

  • Palisades Investment Partners's largest Q4 2025 buy was Travere Therapeutics: 137,768 shares worth $5.26M.
  • Palisades Investment Partners added most to Park Aerospace in Q4 2025, an estimated $628K increase.
  • Palisades Investment Partners's biggest Q4 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $2.16M.
  • Palisades Investment Partners fully exited CoreCard in Q4 2025, selling an estimated $1.35M.
  • Palisades Investment Partners's ten largest holdings make up 48% of its $265M portfolio in Q4 2025.
  • Palisades Investment Partners opened 4 new positions and closed 2 in Q4 2025.
  • Palisades Investment Partners's portfolio value rose 3.9% quarter-over-quarter to $265M.

Based on Palisades Investment Partners's 13F filing for Q4 2025, filed 20 Jan 2026.